{u'keywords': [u'Dr Keung', u'Hong Kong', u'hamilton', u'Mr Blake', u'Dr Ovcharenko', u'AMC', u'distribution agreement', u'Hamilton products', u'urea cream', u'Mr Koerner', u'Hong Kong packaging', u'meeting Dr Keung', u'main Dr Keung', u'Australia Dr Keung', u'Adelaide Dr Keung', u'affidavit Dr Keung', u'DA      Dr Keung', u'Urederm', u'Mr Keung', u'Mak Chu Keung', u'relationship', u'principal Hamilton products', u'parallel importation', u'Chinese character', u'Hong Kong market', u'English language', u'Mr Lock', u'Rubesal', u'evidence', u'Hamilton Laboratories Pty', u'long term', u'business relationship', u'product indications', u'English language product', u'report Dr Ovcharenko', u'Hamilton Pharmaceutical Pty', u'sales', u'intellectual property', u'AMC products', u'Mr Chung', u'analgesic balm', u'Hamilton meeting', u'present purposes', u'time Hamilton', u'China', u'matter Hamilton', u'Hong Kong agent', u'Hong Kong sub-distributor', u'ways Hamilton'], u'casename': u'Australian Medic-Care Company Ltd v Hamilton Pharmaceutical Pty Limited (ACN 008 204 635) [2009] FCA 1220 (30 October 2009)', u'filename': u'training_data/09_1220.xml'}